Axsome Therapeutics AXSM Shares (Basic)
Shares (Basic) at other companies
Other financials
Where this comes from
Reported directly by Axsome Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfSharesOutstandingBasic.
The official record: Axsome Therapeutics’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Axsome Therapeutics's shares (basic).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Axsome Therapeutics's shares (basic)?
- Axsome Therapeutics (AXSM) reported shares (basic) of 51.2M in Q1 2026.
- How has Axsome Therapeutics's shares (basic) changed year-over-year?
- Axsome Therapeutics's shares (basic) increased by 4.8% year-over-year, from 48.9M to 51.2M.
- What is the long-term trend for Axsome Therapeutics's shares (basic)?
- Over 3 years (2022 to 2025), Axsome Therapeutics's shares (basic) has grown at a 7.4% compound annual growth rate (CAGR), from 159.8M to 198.1M.
- What does shares (basic) mean?
- The average number of shares held by investors during the period.
- How do you interpret shares (basic)?
- An increase suggests share issuance, which may dilute existing shareholders, while a decrease suggests share buybacks.
- How does shares (basic) compare across companies?
- Used to normalize earnings across different capital structures in the biopharma sector.